SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-028565
Filing Date
2018-11-08
Accepted
2018-11-08 16:16:51
Documents
62
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q clsd-10q_20180930.htm 10-Q 1233677
2 EX-31.1 clsd-ex311_10.htm EX-31.1 16707
3 EX-31.2 clsd-ex312_9.htm EX-31.2 16700
4 EX-32.1 clsd-ex321_6.htm EX-32.1 9021
  Complete submission text file 0001564590-18-028565.txt   4952045

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT clsd-20180930.xml EX-101.INS 1064505
6 XBRL TAXONOMY EXTENSION SCHEMA clsd-20180930.xsd EX-101.SCH 44213
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clsd-20180930_cal.xml EX-101.CAL 50402
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clsd-20180930_def.xml EX-101.DEF 125940
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE clsd-20180930_lab.xml EX-101.LAB 314849
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clsd-20180930_pre.xml EX-101.PRE 236658
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: GA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37783 | Film No.: 181169881
SIC: 2834 Pharmaceutical Preparations